Clinical trial
Sleep & Move. Systematic Characterisation of Sleep Benefit in Parkinson's Disease. An Observational, Prospective Study
NCT02723396 is registered in ClinicalTrials.gov with Neurocenter of Southern Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sleep & Move. Systematic Characterisation of Sleep Benefit in Parkinson's Disease. An Observational, Prospective Study
- Lead sponsor
- Neurocenter of Southern Switzerland
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 16, 2016
- Completion date
- February 9, 2024
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
idiopathic parkinson disease